Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation68

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation16

Views

Views
September 20252
October 20251
November 20253
December 20251
January 20265
February 20260
March 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Argentina3
Brazil1
Finland1
United Kingdom1
Senegal1
 

Top cities views

Views
San Jose4
Ashburn1
Dakar1
Dallas1
Helsinki1
Imbituba1
Merlo1
Monte Grande1
Pilar1